-
Pegunigalsidase Alfa Elfabrio® as a Long-Term Enzyme Replacement Therapy in Adults With Fabry Disease: A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Costs and Consequences of Cardiovascular Toxicity Due to Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia
Sep 9, 2025, 16:22 PM -
Global Trade Shocks and Exchange Rate Effects on Pharmaceutical Reference Pricing: Implications of EU Stimulus for US MFN Policy
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the AlloMap® Test for the Monitoring of Patients After Heart Transplantation: Economic Evaluation Alongside the CUPIDON Trial
Sep 9, 2025, 16:22 PM -
Organizational and Environmental Impact of Switching From Intravenous to Subcutaneous Immune Checkpoint Inhibitors (ICIs) in France: A Real-World Analysis Using PMSI Data
Sep 9, 2025, 16:22 PM -
Trends and Economic Impact of Medication Errors in Public Hospitals of Eastern Region Ghana: A Retrospective Analysis From 2018 to 2024
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Aztreonam Avibactam (ATMAVI) ± Metronidazole (MTZ) for the Treatment of Complicated Intra-Abdominal Infections (cIAIs) and Ventilator-Associated Hospital-Acquired Pneumonia (HAP/VAP) Caused by Suspected MBL-Producing...
Sep 9, 2025, 16:22 PM -
Cost Analysis of the Extravascular Implantable Cardioverter-Defibrillator Compared to the Subcutaneous System in Patients at Risk of Sudden Cardiac Death in Italy
Sep 9, 2025, 16:22 PM -
A Collection Of Essays on Patient Centricity in Intervention Development
Sep 9, 2025, 16:22 PM -
NICE National Institute for Health and Care Excellence Highly Specialized Technology Evaluations: Use of Pivotal Clinical Trial Outcomes to Inform Relative Treatment Effect and Utilities
Sep 9, 2025, 16:22 PM -
Comparison of the Early Access and Postmarket Evaluation Systems in South Korea and Germany’s DIGA
Sep 9, 2025, 16:22 PM -
Predicting PICOs Through Machine-Learning–Powered Information Compression and Statistical Ranking
Sep 9, 2025, 16:22 PM -
Eligibility and Strategic Implications of Germany’s 2025 Confidential Pricing Reform
Sep 9, 2025, 16:22 PM -
Navigating the Transition: What EU JCA Means for AMNOG Submissions in 2025 and Beyond
Sep 9, 2025, 16:22 PM -
Impact of Mucus Plugs on the Health Economic Burden in Chronic Obstructive Pulmonary Disease (COPD) Patients
Sep 9, 2025, 16:22 PM -
When Cost-Effectiveness No Longer Counts: Industry Views on the Undermining of HTA Principles in Korea
Sep 9, 2025, 16:22 PM -
Utilization of Informal WhatsApp for Pre- and Postnatal Referral Services in the Kwadaso Municipality of Ghana
Sep 9, 2025, 16:22 PM -
Shifts in Medicine Reimbursement in Türkiye: Who Pays for Medicines (2015-2022)?
Sep 9, 2025, 16:22 PM -
Real-life-Persistence to Antifibrotic Treatments in the French Population
Sep 9, 2025, 16:22 PM -
Development of Prioritization Criteria for Implementation and Further Development of HTA Methods: Results From SUSTAIN-HTA
Sep 9, 2025, 16:22 PM
